Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 9 » default
Clinical Pharmacology: Advances and Applications
ISSN: 1179-1438
- View all (258)
- Volume 15, 2023 (3)
- Volume 14, 2022 (12)
- Volume 13, 2021 (27)
- Volume 12, 2020 (28)
- Volume 11, 2019 (16)
- Volume 10, 2018 (19)
- Volume 9, 2017 (19)
- Volume 8, 2016 (20)
- Volume 7, 2015 (14)
- Volume 6, 2014 (23)
- Volume 5, 2013 (30)
- Volume 4, 2012 (11)
- Volume 3, 2011 (7)
- Volume 2, 2010 (28)
- Volume 1, 2009 (1)
Archive: Volume 9, 2017

CRTH2 antagonists in asthma: current perspectives
Singh D, Ravi A, Southworth T
Clinical Pharmacology: Advances and Applications 2017, 9:165-173
Published Date: 15 December 2017

Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma
Pender A, Jones RL
Clinical Pharmacology: Advances and Applications 2017, 9:159-164
Published Date: 4 December 2017

Role of afatinib in the treatment of advanced lung squamous cell carcinoma
Vavalà T
Clinical Pharmacology: Advances and Applications 2017, 9:147-157
Published Date: 27 November 2017

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function
Li Y, Wang X, O’Mara E, Dimopoulos MA, Sonneveld P, Weisel KC, Matous J, Siegel DS, Shah JJ, Kueenburg E, Sternas L, Cavanaugh C, Zaki M, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2017, 9:133-145
Published Date: 8 November 2017

Assessment of prescribed medications and pattern of distribution for potential drug–drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa
Fasipe OJ, Akhideno PE, Nwaiwu O, Adelosoye AA
Clinical Pharmacology: Advances and Applications 2017, 9:125-132
Published Date: 26 October 2017

Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin
Masadeh MM, Alzoubi KH, Al-azzam SI, Al-buhairan AM
Clinical Pharmacology: Advances and Applications 2017, 9:119-124
Published Date: 17 October 2017

Antipsychotic prescription to identify delirium: results from two cohorts
Zimmerman KM, Paquin AM, Rudolph JL
Clinical Pharmacology: Advances and Applications 2017, 9:113-117
Published Date: 3 October 2017

Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases
Dreesen E, Bossuyt P, Mulleman D, Gils A, Pascual-Salcedo D
Clinical Pharmacology: Advances and Applications 2017, 9:101-111
Published Date: 3 October 2017


Etanercept (Enbrel®) alternative storage at ambient temperature
Shannon E, Daffy J, Jones H, Paulson A, Vicik SM
Clinical Pharmacology: Advances and Applications 2017, 9:87-99
Published Date: 21 July 2017

NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatment
North WG, Liu F, Lin LZ, Tian R, Akerman B
Clinical Pharmacology: Advances and Applications 2017, 9:79-86
Published Date: 17 July 2017

Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study
Guragain S, Upadhayay N, Bhattarai BM
Clinical Pharmacology: Advances and Applications 2017, 9:73-78
Published Date: 29 June 2017

Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
Sunkaraneni S, Passarell JA, Ludwig EA, Fiedler-Kelly J, Pitner JK, Grinnell TA, Blum D
Clinical Pharmacology: Advances and Applications 2017, 9:65-72
Published Date: 27 June 2017

An integrated epidemiological and neural net model of the warfarin effect in managed care patients
Jacobs DM, Stefanovic F, Wilton G, Gomez-Caminero A, Schentag JJ
Clinical Pharmacology: Advances and Applications 2017, 9:55-64
Published Date: 18 May 2017

Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study
Iribhogbe OI, Emmanuel I, Odianosen M
Clinical Pharmacology: Advances and Applications 2017, 9:45-54
Published Date: 9 May 2017

Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations
Kohama H, Ide T, Ikawa K, Morikawa N, Nishi S
Clinical Pharmacology: Advances and Applications 2017, 9:39-44
Published Date: 24 February 2017

Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations
Spinks CB, Zidan AS, Khan MA, Habib MJ, Faustino PJ
Clinical Pharmacology: Advances and Applications 2017, 9:29-38
Published Date: 23 February 2017

The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
Frost C, Song Y, Yu Z, Wang J, Lee LS, Schuster A, Pollack A, LaCreta F
Clinical Pharmacology: Advances and Applications 2017, 9:19-28
Published Date: 23 February 2017

Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers
Oh DA, Parikh N, Khurana V, Cognata Smith C, Vetticaden S
Clinical Pharmacology: Advances and Applications 2017, 9:9-17
Published Date: 11 January 2017

Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia
Di Pierro F, Putignano P, Ferrara T, Raiola C, Rapacioli G, Villanova N
Clinical Pharmacology: Advances and Applications 2017, 9:1-7
Published Date: 21 December 2016